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Abstract
Chronic diseases are persistent ailments that are not preventable or curable with medication or vaccination. Many of the
leading chronic conditions in industrialized societies may be related to lifestyle choices. The prevalence of these chronic
conditions significantly affects the health, suffering, and longevity of patients. This paper demonstrates the utility of system dynamics as an approach to model and simulate the behavior of key cost factors in the implementation of population
health management interventions. The study uses modeling and simulation as an evaluative method to identify potential
savings stemming from an intervention within a well-defined population group. The model is flexible in that it allows
policy-makers the ability to set saving targets that, in turn, generate knowledge about the cost structure adjustments
necessary to reach these targets. The model provides useful insights into how the initial estimates of the cost of intervention, the resulting savings, and potential costs adjustments may change. The functionality of the model is demonstrated by means of scenarios implemented via sensitivity analysis.
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1. Introduction
Chronic diseases are illnesses that are persistent and cannot be permanently cured with medication.1 Some of the
most common chronic diseases in the United States
include diabetes, arthritis, chronic obstructive pulmonary
disease (COPD), and congestive heart failure (CHF).
Chronic diseases are the leading causes of disability and
death in the United States and, therefore, extensively
affect activities of daily living for many citizens.2 Nearly
half of all American adults have at least one chronic condition, and one quarter suffer from two or more chronic
conditions.3–5 It has been estimated that approximately
75% of healthcare costs in the USA stem from the management of chronic conditions.6,7
The World Health Organization8 suggests the use of
Innovative Care for Chronic Conditions (ICCC) as a universal framework that considers a wider perspective inclusive of health policy at the macro level and the patients
and their families at the micro level. Weingarten et al.9
view chronic disease as best managed by prospectively
combining multiple interventions, such as education,
appointment and medication reminders, and financial

incentives. Wagner et al.10 offer the chronic care model
(CCM) as a framework to organize interventions, suggesting that intervention elements ranging from individual
patient self-management to informed clinical decisions
work in concert to manage the disease.
There are a substantial number of articles that quantify
the economic burden of chronic diseases. Many methods
have been specifically developed to determine the economic and health effects of interventions on population
health.11 One of the most prominent and widely used
approaches to perform these evaluations is the costeffectiveness analysis (CEA). CEA relates relevant costs
and healthcare effects over a significant time frame.12
However, most of these methods employ metrics that do
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not capture feedback effects of the interventions over time
or second- and third-order impacts on the overall healthcare system.13–16
The relative cost of an intervention, though, may be
conditioned by the choice of which cost elements are
included in the analysis. For example, in most analyses,
only related costs are considered.17 However, unrelated
future expenses stemming from other medical conditions
may also be considered for inclusion in such analyses.
These expenses may result from the extension of a
patient’s life due to the medical intervention itself.18
Within the health economics field in general, it remains
controversial whether to include future costs for unrelated
illnesses and non-medical expenditures within economic
evaluations.19 In addition, there is limited literature that
addresses the time-dependent component of these methods.20–22 From the healthcare delivery perspective, knowledge about the impact of implementing interventions that
extend the life of population groups on a regional ambulatory healthcare system is imperative. For planning purposes, it is critical to know the potential level of resources
required to face prospective increases in the demand when
a set of interventions has been implemented.
Evaluating the efficiency and effectiveness of a chronic
disease intervention is critical, since resources for
implementing such initiatives are likely to be scarce. A
cost–benefit analysis over time to identify the value of an
intervention strategy in terms of consumed resources relative to increased health is meaningful.23 Furthermore, the
ability to quantify the magnitude of cost adjustments necessary to accomplish some level of cost savings while preserving health benefits of a deployed intervention is
significant for policy-makers.
An intervention that is cost saving in the short run in
the sense that it has resulted in less demand for healthcare
services may actually increase healthcare utilization and
costs in the long run. Thus, a mechanism that allows
decision-makers to dynamically investigate the short- and
long-term financial and health tradeoffs associated with
adopting various population-based chronic disease management interventions over time is valuable.
The ability to set monetary and health improvement
goals and understand the systemic consequences and
potential adjustments necessary to accomplish these objectives is critical. Population health approaches, such as the
patient-centered medical home (PCMH) (the US Agency
for Healthcare Research and Quality (AHRQ) provides
decision-makers and researchers with access to evidencebased resources about the medical home and its potential
to transform primary care and improve the quality, safety,
efficiency, and effectiveness; see http://www.pcmh.ahrq.
gov), benefit from the application of these tools since it
views healthcare delivery from the holistic perspective.
Successful population-level management of chronic disease may require consideration of the complex interactions

among medical, behavioral, social, and environmental elements. Healthcare institutions that capitalize on improving
population health while maintaining their financial soundness may be able to retain their competitive edge, and
thus, sustain their operations in the long run.24,25
A simulation model used as a tool to perform these
evaluations over time provides an effective means of testing the effects of interventions on the healthcare
system before implementing. Simulation is highly
regarded as a competent tool in healthcare modeling, since
it has the capacity to capture and process complex information.26,27 Managers may be able to set monetary targets,
for example saving levels, and select any combination of
interventions.
The central objective of this study is to present a system
dynamics model representing key cost factors involved in
implementing a disease management intervention as well
as a mechanism to evaluate cost adjustments required to
accomplish saving targets. A goal-seeking simulation
structure is employed to investigate the cost corrections
required to obtain target savings. The model provides useful managerial insights into how the initial estimates of the
cost of intervention, the cost of care, and the resulting savings may change as target savings are established. As this
paper takes the policy-maker perspective, the model provides constructive insights into how the cost of interventions and potential saving depends upon the uncertainties
and feedback effects.
The paper develops a theoretical simulation framework
that is presented in five sections. Firstly, a brief review of
the literature followed by the research question and
approach are presented. Next, there is a detailed description of the model and simulation results are offered. The
paper then concludes with the discussion of the results and
the potential scope for future work.

2. Background and literature review
The benefits of proper chronic disease management may
include a lessening of pain and suffering as well as extension of life. The management of chronic illnesses may
have impact on the utilization of ambulatory healthcare
services, and therefore, on the regional capacity to provide
these services. Many authors claim that chronic disease
management interventions lead to healthcare savings.23
Fireman et al.28 state that saving may be attained through
the following means: (a) improving quality of health
through use of medications and self-care such that future
complications are prevented; (b) reducing overuse of
healthcare by working with patients; and (c) productivity
improvements by the method of allowing allocation of
some tasks related to interventions from the physicians to
other staff. These authors compare healthcare costs and
quality trends for those under disease management.

Diaz et al.
Goetzel et al.29 review cost–benefit studies in the
chronic disease management context and report that savings from chronic disease management are not realized for
all cases. For example, positive savings are observed for
CHF, mixed results are observed for asthma, and negative
results are reported for depression.29 Most authors use
mortality as a measure to quantify the impact of chronic
disease management interventions. However, evidence of
the effects of chronic disease management interventions
on mortality is unclear for some chronic conditions.
Hämäläinen et al.,30 Roccaforte et al.,31 and GarciaLizana and Sarria-Santamera32 report reductions in mortality among heart disease patients resulting from disease
management intervention programs. Miksch et al.33 report
a reduced mortality among patients enrolled under a disease management program for diabetic conditions. Meigs
et al.34 conduct an analysis of web-based diabetes management interventions and assert the potential to reduce
patient mortality. These analyses, however, do not consider future related and unrelated costs due to increased
life expectancy.
Meltzer17 asserts that, in most cases, the consideration
of future costs has been generally limited to ‘related’ costs
when studying the cost effectiveness of chronic disease
management. The concept of ‘related’ healthcare costs
refers to costs that are directly associated with the ailment.
To illustrate this, Van Baal et al.18 discuss a medical intervention in the form of a heart surgery that saves a patient’s
life. The future heart-related healthcare costs for that
patient is a ‘related’ healthcare cost. However, if the same
patient is treated within the medical system for diabetes
after the heart surgery, then the cost of treating diabetes is
unrelated. These authors claim that inclusion of unrelated
costs when assessing the effectiveness of management
interventions is gaining support.
We argue that it is necessary to consider future related
and unrelated costs to evaluate the benefit of an intervention. Several studies do consider such costs. Chan et al.35
utilize a Markov transition probabilities matrix to characterize the possibility that a patient will survive, be hospitalized, or die. They find that the patients under disease
management have a longer lifespan and, hence, produce
higher future costs to the system. Göhler et al.36 and
Miller et al.37 conduct similar studies and report comparable results. The US Congressional Budget Office38 has
expressed concern that, while interventions are appropriate, from a budgeting perspective the chronic disease management interventions may contribute to projected
increases in demand for medical services, and hence costs
to the overall system, in the long run.
Investment decisions in disease management programs
may be potentially cost effective, but prospectively not
cost saving. Making informed decisions about the longterm projected demands for services such as ambulatory
utilization requires recognition of the numerous
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interactions inherent in the management of chronic disease
and ambulatory systems.15 In the commercially insured
US Medicare and Medicaid populations, for example,
the single largest health expenditure is inpatient utilization
(nearly 33% in 2005), with 13.3% of all emergency
department visits associated with a hospital admission.39
Thus, gauging emergency department visits provides a
reliable indicator of prospective health and monetary
gains. Decision-makers may examine population health
management policies and better understand how various
interventions, several of which are associated with the
concepts of PCMH and population health management
(PHM), dynamically interact to impact the overall health
system utilization relative population health in the presence of chronic conditions. The suggested underlying
model in this paper captures the essential aspects of health
and cost evaluations and allows for the meaningful comparison of intervention strategies.
Continuity care decreases the likelihood of disease mismanagement in vulnerable populations with limited ambulatory healthcare access; for example, Fiscella and
Williams40 discuss health disparity based on socioeconomic disparity. Diaz et al.,15 employing system
dynamics to consider and model access to ambulatory
healthcare services in the US populations managed by
medical homes engaged in PCMH practices, for example,
have evidenced nearly 30% fewer emergency visits and
6% fewer hospitalizations, both of which contribute to
direct savings for the patients and overall savings for the
healthcare system.41 Redirecting low-acuity patients from
emergency departments toward PCMH practices may
prove to be an appealing intervention that contributes to
decongesting these departments. A system dynamics
framework as proposed in this paper draws upon PCMH
and PHM concepts and may have the potential to greatly
enhance the ability of researchers to understand the complexities and costs inherent in chronic disease
management.
System dynamics has been used to analyze the treatment and prevention of chronic conditions within the US
population,14,42 as well as quantifying (Homer et al.
200742) enhanced in care delivery services.43 This
approach has been used to model the progression of particular chronic ailments, for example diabetes by Jones
et al.44 and Milstein et al.45 The development of a system
dynamics model that considers generic components of
chronic disease management costs is developed by Diaz
et al.16 and Diaz and Behr.46 Goal-seeking structures from
system dynamics have been used to represent and simulate
local search mechanisms that seek to quantify potential
adjustments, for example Kim and Springer47 and more
recently Georgiadis and Michaloudis.48
Table 1 exhibits a very short sample of papers that use
system dynamics and other methods and metrics to perform these types of evaluations.
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Table 1. Sample of papers that use system dynamics and other methods.
Reference

Brief Description

Freeman et al.49

Present an evaluation of alternative health policies or treatment programs in
which the numbers of quality-adjusted life years (QALYs) produced for each
patient are added up to obtain an aggregate measure of program effectiveness.
Investigate deterministic and probabilistic models for healthcare economic
evaluation while considering five different types of discounting functions.
Present a test of the predictive validity of various classes of economic evaluation
models (i.e., linear, power, and exponential models).
Use an evidence-based system dynamic simulation model. They find that
expanding insurance coverage and improving healthcare quality would likely
improve health status. The authors find that will raise costs and worsen health
inequity.
Evaluate interventions of treatment adherence in patients with multiple chronic
conditions (MCC).
Suggest research in health services that includes: (1) considering MCCs and
disabilities in comparative effectiveness research (CER) and assessing quality of
care; and (2) identifying and evaluating the data needed to conduct CER,
performance measure development.
Estimate economic health indicators for smoking and obesity for the USA.
Analyze the impact of using the quality-adjusted life year (QALY) as a routine
summary measure of health outcome for economic evaluation.
Review the benefits of using small system dynamics models to address public
policy questions.
Revise research literature on simulation modeling as support for healthcare
decision making and proposed steps essential for the success of simulation
projects.
Study the association between the number of chronic conditions and selfreported health-related quality of life (HRQOL).
Suggest interactive simulation modeling and game-based learning to support
innovation in the planning process.

Hansen and Østerdal50
Abellán-Perpiñán et al.51
Milstein et al.52

Jansà et al.53
Iezzoni54

Jia and Lubetkin55
Whitehead and Ali56
Ghaffarzadegan et al.57
Forsberg et al.58
Chen et al.59
Hirsch et al.60

3. Research question and approach
A variety of chronic disease management interventions
have been deployed to help patients live with their disorders. The central idea of implementing such interventions
is to enhance their health conditions. In addition, these
interventions might aim to achieve cost savings through a
reduced healthcare utilization rate. Although the implementation of these interventions is attractive from the clinical perspective, the financial outcomes may be unknown.
Many authors analyze the short-term saving impacts while
disregarding future healthcare costs and their implications.
The use of system dynamics simulation allows users to
investigate the short- and long-term monetary and population health impacts associated with adopting various
population-based chronic disease management interventions. Furthermore, it allows decision-makers to establish
saving targets and investigate prospective cost adjustments
to accomplish these aims.
This characterization presented in this paper provides a
mechanism that allows for assessing required cost adjustments in the presence of interventions. The approach suggested in this paper involves the following: representing

the flow of patients with given pre- and post-intervention
profiles; representing the main cost elements that affect
the implementation of intervention strategies; representing
budgetary constraints that determine the ability to generate
savings; and characterizing cost-effectiveness evaluation
mechanisms that allow for quantifying health and cost
impacts of the potential interventions to implement. The
measure of cost effectiveness is critical in this context,
since decisions have to be made regarding the selection of
new treatments that can be offered to patients in the face
of budget constraints. In such a situation, the treatments
that are most cost effective become candidates for selection as they ensure the best possible utilization of available
dollars.
Unlike other models presented in the literature, the
model suggested in this paper allows for establishing monetary aims in terms of prospective savings to be attained.
Furthermore, the model permits ascertainment of cost
adjustments required to accomplish these aims, and thus,
sheds light on the potential cost-related endeavors that
decision-makers should engage in order to obtain such
savings over time.

Diaz et al.
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Figure 1. Causal-loop diagram for the proposed model.

4. Model description

4.1. Basic structures

The objective of the model is two-fold. On the one hand,
the model assists policy-makers in determining how the
deployment of a theoretical chronic disease management
intervention may alter the utilization of healthcare services
over time and, by extension, impact the overall cost to the
system. On the other hand, the model includes a goalseeking adjustment mechanism, in which cost behaviors
are dynamically adjusted until a predetermined ‘saving target’ value is achieved and maintained through the course
of the simulation. For simplification purposes, the model
considers two essential cost structures: the cost of the intervention per patient and the cost of care per professional
visit. The high-level causal-loop diagram that summarizes
the connections among model components is illustrated in
Figure 1.
The way that the model is set can be described by two
co-flows that simultaneously consider the health and
financial consequences given a set of initial conditions.
One branch represents the behavior of the utilization of
the ambulatory system in the absence of intervention,
while the second branch mirrors similar dynamics in the
presence of an intervention, such as the one described in
Section 1. This mechanism provides an opportunity to
dynamically calculate savings as the difference between
the pre- and post-intervention costs. In addition, in the
presence of an intervention, the model allows for setting a
saving target that permits cost constraint relaxations driven
by some degree of elasticity in each cost component. Coflow and evaluating structures that consider elasticity components are extensively explained by Sterman.61. A
detailed description of the basic model structures as well
as rationales that support their inclusion follows.

The model considers five critical structures that relate one
to another and includes populations’ pre- and post-intervention, healthcare utilizations by each population group,
intervention health effects, health and intervention cost
components, and goal-seeking mechanisms. Since the
focus of the model is on contrasting pre- and postintervention costs while allowing for setting saving targets,
the central characteristic of the model is to dynamically
contrast the financial and health consequences from
deployment of interventions whose target savings are set
to a numerical value.
The population pre-intervention component involves
three basic characteristics of the population group target.
The main features that characterize these groups include
their health status, mortality rates, and per capita utilization of ambulatory services. These features define the total
ambulatory utilization of the pre-intervention population
group over time. Likewise, the population postintervention component assumes the same attributes that
characterize the pre-intervention population in addition to
other characteristics that include an aging delay and intervention target population. The age delay factors life extensions caused by a theoretical application of interventions
that are assumed to extend life expectations. The intervention target population variable assumes that only one portion of the population that receives the intervention
successfully experiences the benefits from the application
of the theoretical intervention.
The utilization of the ambulatory system has a cost that
is captured by the actual cost of care per patient and is
independent of the intervention. This cost component
refers to all of the direct and indirect costs that support the
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healthcare system in which the patient is served; for example, all of the administrative and overhead costs involved
to keep the healthcare service running. An important property of this actual cost per patient is its elasticity, which
reflects the degree of flexibility that can be adjusted in the
presence of internal and external pressures, for example
gains in efficiency and productivity as pointed out by
Fireman et al.28. In addition to this actual utilization per
capita health cost, the total post-intervention cost contains
the per capita intervention cost.
The per capita intervention cost entails the expenditures
associated with solely applying an intervention set to the
aimed population group; for example, the cost of applying a
vaccine or educating diabetic populations to measure their
glucose levels at appropriate time intervals. Similar to the
actual pre-intervention utilization costs, this cost has an associated elasticity that reflects the degree of flexibility that
may be accomplished when external and internal forces exert
pressure on the cost component, for example when administrating a vaccine may be accomplished orally in lieu of an
intramuscular injection whose cost may be superior.
Actual savings are obtained by dynamically calculating
the differences between post-intervention costs from the
pre-intervention costs over time. Thus, the savings can be
calculated for two specific situations: (1) comparing intervention effectiveness versus the absence of interventions;
and (2) targeting specific savings versus the absence of
interventions. The targeting specific savings scenario
assumes the existence of an intervention scenario and
compares savings when a target saving level is established
with a situation in which target savings are absent. The
general workings of the simulation model under these scenarios may be described as follows.
Both the pre- and post-intervention population stocks
are initialized simultaneously. Given pre- and postintervention conditions, both stocks lead to values of the
healthcare utilization over time. As described before, the
intervention population stock is influenced by health status
improvements. Visits per patients and costs are employed
to determine quality-adjusted life years (QALYs) and costeffectiveness ratios that vary over time. This provides
referential points that are considered when determining
care and intervention costs, as well as changes in intervention budgets that influence healthcare expenditures. These
influences pace the rate that savings are depleted over time.
Thus, when a target saving exists, a saving pressure is generated and exerted over the cost components. Given elasticity values for each component, these cost components
adjust over time, generating shifts in cost-effectiveness
ratios that influence intervention budget expenditures, and
thus, keeping savings to the desired level of performance.
Each cost component has an associated elasticity that
reflects potential gains that can be accomplished by
improving the structure cost component. In this sense, it is
assumed that the cost per intervention is constrained and

has limited adjusting power that can be employed to
improve efficiency. Conversely, the cost of care is
assumed to have a larger elasticity and allows more flexibility for improvement. The cost of care reflects systemic
costs associated with delivery that encompasses many
other overall costs of administration. As time progresses,
the cost of care increases, and the saving obtained from
applying the intervention may not be adequate to preserve
the target savings. Thus, a pressure is generated to increase
the efficiency in the cost of care and cost per intervention.
Given the elasticity components, the cost of care and cost
per intervention adjust correspondingly. These costs
impact the cost-effectiveness ratio that further affects the
budget per patient and can be compared to the preintervention and post-intervention utilization. Utilization
levels determine cost contributions to savings. These savings are recurrently contrasted with the target savings and
trigger the goal-seeking cost adjustment structures as previously described.
The positive loop intervention Improvement R1
describes the overall dynamics of improvement in the
patients’ health, after the application of a medical intervention. This is illustrated by the Additional QALY,
which is the difference between the QALY post- and preintervention. As health-related quality of life increases,
then so does the cost per QALY gained, and ultimately the
cost-effectiveness.63 As the population grows, so does the
rate of people that seeks ambulatory services. As intervention effectiveness increases the longevity post-intervention, more people might seek ambulatory services.63
Patients could enjoy an extended life span, longer than it
would otherwise be without intervention, which may
potentially lead to an increase in resource utilization.64,65
The negative loop Spending Control B1 presents the
goal of balancing and increasing the actual savings. An
increase in savings causes the savings pressure to decline.
As indicated, the savings in costs is expressed by the gap
between the spending pre- and post-intervention. As this
target saving is not attained, the pressure to reduce total
costs increases, leading to an adjustment in cost of care
per patient.66 A lower cost coupled with a high utilization
rate through doctors and emergency room (ER) visits67,68
causes the post-intervention spending to rise. This
spending lowers the savings in healthcare costs while the
pre-intervention spending raises it. Efforts to decrease
post-intervention expenses contribute to an increase in the
savings generation, which in turn reduces the savings
pressure.
The negative loop Cost Control B2 has a similar objective as the B1 loop, which is to reduce savings pressure.
This loop balances the costs of intervention for patients.
As the savings pressure increases, the cost of intervention
per patient declines.69 Reduction in this cost causes the
total cost of intervention to mount given the growth of the
fraction of patient population target for intervention.

Diaz et al.
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The positive loop Cost Effectiveness R2 represents the
impact of the savings pressure on the intervention cost
effectiveness. As seen in loop R1, an increase in the Dollar
per QALY cost-effectiveness leads to an increase in budget, which allows for a higher number of patients to be targeted for the intervention. As the quantity of patients with
improved quality of life increases, the longer life expectancy increases the total cost of care.70 These costs are
compared to the savings in healthcare in order to generate
actual saving.

4.2. Governing equations

v=

This section presents the central equations that govern the
simulation model from the stock and flow model. The
stock and flow model is not included in this paper due its
size and complexity. Unlike the description of the causalloop diagram presented in Section 4.1, this description
presents further details of the rates and stocks that are critical to the functioning of the model. Thus, a direct correspondence between each component of the causal-loop
diagram to each equation presented here is not applicable
as these equations present further model details. A brief
description of the main stock and flow that provides further modeling details follows.
The Change in the Pre-intervention Population over
time is defined by dPP=dt = ldPP=dt = l, where l is the
Net Population Change Pre-intervention Rate. l is given
by the relationship between the Effect of Longevity on Net
Birth Rate, ELBRP, the Effective Survival Rate Pre-intervention, ESRP, the ratio of Initial Population to the Base
Population, IP/BP, and the Change of Total Population
Pre-intervention over time, PP(t) as shown by (1):
l = ELBRP 3 ESRP 3 IP=BP 3 PP(t)

ð1Þ

Likewise, the Change in the Population Post-intervention over time is defined by dPOP=dt = a; similar to l,
the Net Population Change Post-intervention Rate, a, is
defined by the relationship between the Effect of Longevity
on Net Birth Rate Post-intervention, ELBRPO, the
Effective Survival Rate Post-intervention, ESRPO, the
ratio of IP/BP, and the Change of Total Population Postintervention over time, POP(t) (2):
a = ELBRPO 3 ESRPO 3 IP=BP 3 POP(t)

To gain knowledge of the impact of an intervention,
projections of the adopted metric must be generated over
time.72 The most effective course of action, and therefore
the most competent treatment, are determined by the intervention strategy that displays the lowest per dollar
QALY.73 This traditional Cost Effectiveness measurement
is defined by the ratio of the difference between the cost
of the two intervention situations and the difference
between the QALY related to each treatment. The Cost
Effectiveness, v, is given by the following equation:

ð2Þ

A pre- and post-intervention per capita healthcare utilization value is assumed to estimate the total patient visits.
For example, the portion of a chronic disease population
that is not well managed (e.g., pre-intervention) generates
a certain level of per capita healthcare utilization (e.g., 3.5
visits per year). Conversely, the same portion of the population engaged in a chronic disease management (e.g.,
post-intervention) will produce relatively less per capita
utilization (e.g., 1.5 visits per year).71

(Costs post intervention  Costs pre intervention)
Additional QALY gained
ð3Þ

The target patient population uses the healthcare system
prior to and after the deployment of theoretical intervention. The model determines Healthcare Spending simultaneously for both population flows and calculates the
prospective Cost Saving by computing the difference
between the two associated healthcare expenditures. The
Population Pre-intervention affects the Pre-intervention
Utilization that determines the Healthcare Spending Preintervention. The Longevity Pre- and Post-intervention
affect the QALY Pre- and Post-intervention, respectively.
Both the population flows affect also the Total Utilization
Pre- and Post-intervention, which in turn determines the
Healthcare Spending.
The Intervention Budget stock represents the change in
the intervention budget deployment over time and is
defined by dB=dt = n  k, where n represents the intervention investment rate in which money from scheduled
intervention deployment is invested and accumulated in
the budget stock, while k represents the budget depletion
rate. n is related to the Average Cost Effectiveness that
influences the pace at which intervention investments flow
into the budget during the deployment period. This model
presupposes that intervention will be implemented in the
first years of the evaluative period. The Expenses Rates is
given by (4), where CIPP is the Cost of Intervention per
Patient, EFT, the Effective Fraction of Population Target,
Population, POP(t), and the Change in the budget over
time, BðtÞ:
u = IVR 3 CIPP 3 EFT 3 POPðtÞ 3 BðtÞ

ð4Þ

The Actual Cost of Care Post-intervention, ACPI, is
defined by (5) and is related to the Cost of Care per Visit
Post-intervention, CCVPostI, the Effective Outcome of
Targeting, EOT, the Average Visits, AV, and the Cost of
Care per Visit Pre-intervention, CCVPreI, as follows:
ACPI = ðCCVPostI 3 EOT 3 AV Þ
+ ðCCVPreI 3 AV 3 ð1  EOT ÞÞ

ð5Þ
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Both pre- and post-intervention healthcare expenditures
determine the level of savings, as denoted by Savings in
Healthcare Costs. The change in the Savings over time is
provided by dS=dt = r  cdS=dt = r  c, where r is the
Savings Credit Rate while c is the Savings Depletion
Rate. r is defined by difference between the Pre-intervention Cost of Care per Intervention, and the Actual Cost of
Care Post-intervention, which control the accumulation of
Savings. c is determined by the Average Budget Expenses,
c = EðtÞ, and varies over time. It represents the effects of
intervention budget reductions that are smoothed out over
time to capture delay effects that stem from the time differentials between spending money for the intervention
deployment and the effects on savings.61
In the savings target scenario, the goal-seeking structure adjusts over time until the system stabilizes when the
savings pressure from the target is reduced to near zero.
The Savings Pressure, SP, is defined by the difference
between the Target Savings, TS, and the Post-Intervention
Actual Savings, AS. The presence of this difference forces
the model to adjust the Cost of Care Pressure, CCP, and
the Cost of Intervention Pressure, CIP. When the difference is large, the pressure for adjustments is proportionally
large, and therefore the cost adjustments of that intervention are large.
The magnitude of influence that the SP has on both
the CCP and CIP can be characterized as Equations (6)
and (7). This influence is driven by the elasticity associated with the each of these variables. By definition, the
elasticity determines the degree of change in the parameter in response to a unit change in the effectors,74
which in this case corresponds to SP. The system
responds to these pressures by adjusting costs and reducing the gap created between the actual and target savings
until this difference is negligible, meaning the savings
pressure relaxes:61
Cost of Care Pressure =
Cost of Care Elasticity 3 Savings Pressure
Cost of Intervention Pressure =
Cost of Intervention Elasticity 3 Savings Pressure

ð6Þ

ð7Þ

The Actual Cost of Intervention per Patient, ACIPP,
and the Actual Cost of Care per Patient, ACCPP, are
influenced by the CIP and the CCP, respectively. The
Total Cost of Intervention, TCI, is determined by the Cost
of Intervention per Patient, CIPP, the Total Patient
Population, TPP, and the Fraction of the Patient
Population Targeted that is aimed for the intervention,
FPPT.
The ACIPP also includes an amplification cost component that seeks to reflect increases in cost care per patient
over time.13,38 This increase further erodes the potential

savings from the implementation of interventions. This
erosion leads to a decrease in Cost Effectiveness.
Decreases in Cost Effectiveness reflect major cost
reductions required to meet target savings. Since fewer
costs are used to accomplish the same health benefits,
Cost Effectiveness metrics reflect this attrition.
However, efficiencies in the healthcare system are
indirectly accomplished by reductions in costs via
exerting pressures on their structural components based
on allowable elasticity, as mentioned in the introduction of Section 4.
Decreases in savings lead to increases in saving pressure that constantly seek equilibrium given the target savings by adjusting cost components and continuously
evaluating resulting outcomes. This path-adjustment cyclical process is repeated through the life of the entire run
until the execution ends.

5. Simulation and results
Prior to executing the simulation, initial parameter values
must be set. Different sets of initial values characterize
dissimilar theoretical scenarios. These results are believed
to assist in developing managerial insights on the cost
effectiveness of implementing a set of interventions and
how these costs may change over time. Furthermore, these
outcomes provide guidance in cost corrections that may be
necessary to obtain target savings. As indicated before, the
objective of this framework is to characterize and observe
the system behavior that embeds a goal-seeking structure
under certain conditions. Thus, independently of the values employed, the capability to set an evaluating structure
capable of mimicking the dynamics of cost adjustment
endeavors required to accomplish a given saving target is
sought in this article. A combination of real-world and theoretical values is assumed while focusing on the agreement of the generated behavior.
Each scenario may be simulated by producing a different tendency. Table 2 exhibits selected values employed to
initialize the simulation. The table indicates two sets of values that include (A) for global parameters that contain values assumed for the entire simulation and (B) parameters
that are exclusively associated with the intervention. For
example, consider the Cost of care elasticity that is
assumed to be 0.1, which reflects a theoretical buffer that
allows decision-makers to optimize their resources and
operations. Conversely, the Cost of intervention elasticity
is assumed to be 0.01, which theoretically reflects the cost
rigidity associated to applying an intervention. Perhaps, the
costs of calling a patient to follow up and remind him or
her to take medication have a lower degree of cost flexibility and may be marginally affected by its elasticity.
The health status pre-intervention is assumed to be 2
on a 1–5 scale and the pre-intervention per capita
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Table 2. Initial values.
Constant

Value

Unit

Description/source (citation)

A. Global parameters
Cost of care elasticity
Cost of intervention elasticity
Cost of care per visit pre-intervention

0.1
0.01
146

Dollar/Year
Dollar/Year
Monetary Unit/Visit

Initial population

100,236,820

Person

Intervention visit rate

3.7

Visit/(Person*Year)

Min initial targeting

0.5

Dmnl

Pre-intervention per capita utilization

3.41

Visit/(Year*Person)

Quality of life pre-/post-intervention

0.48/0.52

Dmnl

Target savings

55,000

Monetary Unit/Year

Capacity of the cost of care to change.
Capacity of cost of intervention to change.
Cost per visit per patient, before the application
of the intervention.75
Total population in the Southern area of the
US.76
Visit rate required by the intervention for
patients.77
Percentage of people suffering from any type of
chronic condition.78
Visit rate pre-intervention for the Southern
region.79
Improvement of health with the application of
the intervention, for example, Mishel et al.80
Total amount of money to be saved due to the
application of the intervention, e.g., 14,000–
69,000.81

B. Intervention parameters
Budget

3,853,305

Monetary Unit

Cost of intervention elasticity
Effectiveness rating intervention

0.01
0.5

Dollar/Year
Dimensionless (Dmnl)

Increase in longevity
post-intervention factor
Initial estimated cost of
intervention (average value)
Initial estimated cost post
intervention (average value)

3.6

Year

17.5

Monetary Unit/Visit

132

Monetary Unit/Visit

Intervention visit rate

3.7

Visit/(Person*Year)

Post-intervention per capita utilization

2

Visit/(Year*Person)

Quality of life pre-/post-intervention

0.48/0.52

Dmnl

Threshold cost effectiveness

139

Monetary Unit/Year

utilization 3.41 visits per year, as pointed out by the literature in the target population. This has been modeled
using stochastic function, which is consistent with the
widely available literature and adds more realism to the
model. The uncertainty factor has been embedded in
per capita utilization through a random function that
reflects some unexplainable randomness. Parameters
such as the effectiveness of the intervention, the initial
estimated cost of intervention, and cost of care or the
effect of intervention on the per capita visits rate are
assumed to be stochastic.
The first scenario considers the model performance
when an intervention has been implemented but target savings are absent. The second scenario considers the situation in which a decision-maker projects implementing an
intervention, and simultaneously, sets a target saving to

Initial budget allocated for the application of the
intervention. It depends on the initial cost of the
intervention76 and the total number of visits.82
Capacity of cost of intervention to change.
Percentage of the successful intervention on
targeted patients.83
Healthy days/years gained in pre-intervention.83
Cost of intervention. Money paid for disease
management intervention.84
Cost of treatment post-intervention that may be
absorbed by healthcare institution and/or paid by
patient.75
Visit rate required by the intervention for
patients.77
Prospective visit rate post-intervention for the
Southern region.
Improvement of health with the application of
the intervention, for example, Mishel et al.80
Limit/least benefit on yearly basis for an
intervention to be labeled as cost effective.84

accomplish. As a result, the main difference between scenarios is that the target savings in the first scenario are
zero while the second scenario considers the saving target
as the goal.
The scenario analysis examines the impacted cost structures when the goal-seeking mechanism is employed versus the situation in which this mechanism is not employed
in the presence of an intervention deployment. The simulation model is executed under two particular scenarios for
a period of 50 years. The rationale is to observe how the
relevant system variables perform under ‘Intervention
Deployment and Target savings is zero’ versus
‘Intervention Deployment and Target savings is different
than zero.’ Vensim from Ventana Systems Inc. was utilized to execute this simulation. The system behavior is
described below.
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Figure 2. Patient visits.

Figure 3. Net savings intervention zero-saving target.

5.1. Scenario 1: Intervention Deployment
and Target savings is zero
The purpose of this scenario is to observe the behavior of
key system elements under the intervention scenario when
target savings are absent. Once again, in this scenario, the
goal-seeking structure that strives to obtain a predetermined level of savings is not employed. Figure 2
shows that the total visits by patients that have been
exposed to the intervention initially are fewer compared to
the situation in which the deployment of an intervention is
not present. This behavior agrees with the expected effects
of the intervention. Notice, however, in the long run, the
visits rate in the ‘intervention zero-saving target’ setting
exceeds those in the ‘no intervention’ setting. This
increase results from the life extension obtained by the
application of the intervention that produces an increase in
per capita utilization at advanced age. Once again, this
tendency is expected due to the increase in the likelihood

Figure 4. Net savings intervention target savings different than
zero.

of developing one or more chronic conditions, as previously discussed.
The savings accumulation in the ‘intervention zerosaving target’ may be seen in Figure 3. Consistent with
the literature, one may observe that ‘intervention zerosaving target’ setting produces higher net savings in the
short term, since the system experiences a decrease in
utilization. These savings are later eroded as the per
capita utilization and the cost of utilization escalate due
to aging and life extension, as well as increases in projected cost of care over time. This result suggests that the
theoretical disease management intervention employed
in this model may generate savings in the short run, but
in the longer term, these saving are compromised.17,18,84
This result advocates for the need of resource planning in
ambulatory settings that considers projections in healthcare requirements.15,85,86

5.2. Scenario 2: Intervention Deployment
and Target savings is different than zero
This scenario contrasts the behavior of the system for the
situation in which the target savings are set to an arbitrary
value versus the situation wherein this target is zero. In the
first case, the target savings of the system are set at an
arbitrary 40,000 monetary units (perhaps dollars), while in
the second case the target savings are set to zero. Figure 4
illustrates the resulting net savings from both cases. When
the target is set at 40,000 monetary units, the goal-seeking
structure adjusts the cost of care and the cost of postintervention components of the model to produce the
higher net savings. Notice that initially both cases report
modest levels of savings. When the target savings is different than zero, the behavior of the system suggests that
the target savings can be accomplished. However, to
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Figure 5. Cost of healthcare per visit.

Figure 6. Cost of intervention per patient per unit time.

produce these savings a significant adjustment in the cost
structure may be required.
Figure 5 exhibits the extent of the adjustment required
in cost of care per patient to accomplish the target savings.
These results suggest that to accomplish such savings, the
downward adjustment of the cost structure requires major
efforts. The required reductions in cost of care per patient
to obtain the target savings can be accomplished by
streamlining the processes involved in the care of patient
that manage their chronic condition (e.g., following up
care via technological devices), as previously discussed in
Section 2. The cost reduction is not as severe in case of the
cost of intervention per patient, as observed in Figure 6.
This is caused by the limited effects of the elasticity associated with the cost of intervention, as assumed in this
paper. In general, the cost of intervention per se is found
to be significantly lower than the elements associated with
the cost of care, as discussed in Section 4. As a result, the
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Figure 7. Cost of care post intervention.

net savings obtained from reducing the cost of intervention
are far less than the net saving that can be obtained by
reducing the cost of care. This is reflected in the model by
setting the elasticity of the intervention to be far lower
than the elasticity of the cost of care.
This scenario assists in understanding the consequences
that the healthcare system has to face if the target savings
have to be achieved. In a more practical sense, this scenario helps decision-makers in identifying the magnitude
of cost efficiency that has to be brought about in their system resulting from the intervention, if the target savings
are to be realized. The information generated by the model
can be employed to gain knowledge to plan and engage
cost improvement programs that assist in enhancing the
ambulatory cost structures, as indicated in Section 2. In
this sense, public health officials, for example, may be able
to explore realistic intervention alternatives that allow not
only increasing health status of the target population, but
also pursuing monetary savings that may require further
systematic changes in healthcare delivery endeavors.

5.3. Sensitivity analysis
In this paper, the Cost per visit per patient is selected as
an independent variable while Cost of care per visit postintervention, Actual cost of care post-intervention, and
Cost of intervention per patient in the presence/absence of
target savings are selected as dependent variables.
Furthermore, three levels of Cost per visit per patient are
considered: US$126, US$146, and US$166. Figures 7–9
display the results obtained from conducting the sensitivity
analysis to analyze the effects of changes in the Cost per
visit per patient levels. Slight fluctuations in the performance of each cost behavior may be observed due to the
introduction of a stochastic component. As indicated, these
distribution functions represent the uncertainties in
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2.
Figure 8. Cost of healthcare per visit.

substantial while departing from the savings target,
cost post-intervention adjustments are adjusted
considering their associated elasticity. These
adjustments seek to stabilize the actual savings as
such that targets are maintained. In addition, the
effects of cost amplifications experienced over
time influence the cost adjustment required to
obtain the target savings. These cost amplification
effects increase the cost-related effort required to
accomplish the established saving goals. Clearly,
the more substantial and significant is the amplification factor, the more pronounced the required
cost adjustments will be.
Each curve departs from the positive trend of
growth as the target savings are accomplished.
When the cost level increases from US$126 to
US$146, and from US$146 to US$166, departures
from their increasing tendency initiate as each tendency reaches the target savings. These timing differences are explained by the effects produced by
the accumulated savings of each curve over time.
A substantial difference creates a considerable gap
between the actual and the target savings. The
more substantial the difference between actual and
target savings is, the faster the cost adjustment
occurs, and consequently, the more significant the
required budgetary adjustments endeavors will be.

6. Summary and managerial implications

Figure 9. Cost of intervention per patient per unit time.

intervention costs.87 Based on the behavior of each curve,
two observations may be noted.
1.

The cost curves whose targets are absent continue
to grow over time while the ones whose targets are
set display a slight initial decline and leveling that
departs at different times and vary per Cost per
visit per patient level. In the Cost of care per visit
post-intervention chart, this decline is more pronounced. This decreasing and leveling is explained
by the presence of the saving target and the action
of the goal-seeking structure and the negative feedback loop acting in the model as the time progresses. The initial decline represents early cost
adjustments necessary to reach the target saving.
As explained previously, savings are computed as
the difference between the costs pre- and postintervention. Thus, when this difference becomes

Chronic diseases in the US constitute a sizable portion of
healthcare expenditures and are projected to increase along
with the aging population. PCMH is a well-known
approach for continuity care that promotes disease management for mitigating some of the negative effects stemming from chronic disease. Although the appropriateness
of deploying disease management interventions is widely
recognized, the cost-saving potential, or at least the costneutrality of such interventions, is debatable.
Cost evaluations of disease management interventions
are convoluted by a number of uncertainties in estimating the
actual cost of delivering the intervention, the impact of intervention on the actual utilization of the system, and the overall
cost to the healthcare system in the long term. Although
inconclusive, the literature does suggest that certain disease
management interventions can be cost saving in the short
term. However, the cost-saving potential over the long term
appears less favorable. Longer term cost-saving analyses
based on Markov models indicate that, although disease management interventions are likely to be cost effective, they are
unlikely to be cost saving in the long term.
This paper presents a system dynamics simulation
model that provides a mechanism to analyze the health
and monetary impact of deployments of interventions.
Furthermore, it provides a tool to evaluate cost
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adjustments required to achieve specific savings aims. The
model suggested in this paper presents a synthetic representation that reflects the dynamics of the real-world system and helps in analyzing various cost issues in the
implementation of chronic disease management programs.
This model embeds a goal-seeking mechanism to explore
the effects of target savings on the main cost component
structures and allows quantifying cost-adjustment efforts
to realize these savings. The applicability of this model is
demonstrated using two scenarios in which the presence
and absence of target savings is assessed.
The analyses of the scenarios indicate that the application
of interventions is likely to result in a decrease in utilization
and an increase in savings only in the short term. Savings and
utilization gains are eroded in the longer term since selected
interventions lead to life extension that results in increasing
prospective ambulatory utilizations stemming from increasing
opportunities for the development of additional or multiple
chronic diseases in an aging population. As some interventions extend individuals’ longevity, the probabilities of ambulatory visits increase, in particular in elderly populations
whose natural health is declining and major ambulatory utilization is expected. Such a scenario analysis is of value to stakeholders, since anticipation for planning for resources that
participate in healthcare delivery is critical for matching the
supply with the demand. From the operational perspective,
this matching is essential to maintain optimal customer satisfaction and improve opportunities to maximize revenues.
From the healthcare point of view, timely matching of available resources and patient needs increases healthcare access,
which reduces population health disparities.
This study involved several limitations. Although most
values employed in the simulation are actual values, the
application of the evaluating framework does not seek to
shed light on the effects of particular populations or interventions on healthcare systems. Generalization or the development of a case study was not a major purpose of this study.
As a countless number of simulation studies can be found in
the Operational Research literature, the focus of this paper is
on providing a mechanism that may assist decision-makers
in quantifying their managerial endeavors. In particular, the
aim of this paper was to illustrate the use of goal-seeking
structures to determine cost-adjustment efforts in the presence of a chronic disease management intervention.
Some of the mathematical expressions described in this
paper have been simplified for demonstration purposes.
Elasticity expressions, for example, have been assumed to
be constant, while some research streams claim that the
elasticity may present an exponential behavior based on
development of underlying theories. Studies are underway
to mathematically customize these expressions, and hence,
to develop a model that contributes to the healthcare management of a particular community.
This study is significant for several reasons. Firstly, this
research extends the relatively limited literature on the
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application of system dynamics to model critical components of the ambulatory healthcare system and its interaction with the application of chronic disease management
interventions on population groups. It is asserted that
decision-makers have to consider a large number of factors
and interdependencies that are critical for the performance
and sustainability of the healthcare system. A system
dynamics approach offers a logical and intuitive modeling
and simulation process that captures key complexities.
Secondly, the simulation framework used to develop
the model presented in this paper provides an alternative
estimation of the ambulatory demand method that explicitly considers interdependencies and feedback loops
related to enhancements in population health. These
enhancements stem from the application of successful
interventions that decrease mortality rates in certain population groups and prospectively increase utilization
rates caused by natural health decline in the elderly.
Identifying the best possible balance among cost, responsiveness, and quality care, considering an evolving
demand affected by successful interventions, requires
tools that are capable of mimicking the reality of the system. Thus, healthcare managers may explore tradeoffs
among proposed solutions.
Next, an understanding of the cost adjustments required
to accomplish certain savings is central to the planning for
the supply of healthcare personnel that will potentially
face increases in the demand for ambulatory health services. Employing a modeling approach rooted in recognizing the evolving behavior of the demand and that is able to
connect ambulatory utilization and health/cost impacts of
interventions on population groups makes possible a more
holistic understanding of the regional healthcare system.
Thus, the model enables an understanding of the forces
that create the mismatch between the supply and demand
while providing opportunities to investigate and address
this mismatch as well as health disparities.
Lastly, the suggested characterization holds the possibility to extend a further investigation of the dynamic interactions of particular interventions and specific population
groups. Thus, it facilitates a better understanding of how a
combination of potential interventions affects the supply
and the demand, and how budget cuts and or saving targets
may impact the endeavors required to accomplish the same
health effects on population groups. In addition, the explicit analysis of these interventions can be used as input for
sensitivity and elasticity of each intervention relative to
both the patient population and the resources used to the
deliver healthcare services.
Funding
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